Department of Pharmaceutical Sciences, State University of New York, 427 Cooke Hall, Buffalo, NY 14260, USA.
J Neurol. 2012 Apr;259(4):637-44. doi: 10.1007/s00415-011-6226-3. Epub 2011 Sep 6.
To assess the patterns of dietary (DS) and herbal supplement (HS) use in MS patients, compare use between MS patients and healthy controls and to identify potential interactions with drugs used to treat MS. This study included 279 MS subjects and 161 controls from a study of risk factors in MS. All patients received a neurological examination. All subjects provided responses to a standardized questionnaire administered during an in-person interview. A larger proportion of MS patients (82.1%) compared to controls (60.1%) used one or more DS regularly for at least 3 months (p < 0.001). There was a trend toward a higher proportion of MS patients (26.6%) versus controls (17.8%) who used HSs for more than 1 month (p = 0.038). The most common DS used after MS onset was a multivitamin (78.1%), followed by vitamin D (65.8%). Use of the majority of specific DSs increased significantly after MS onset compared to before. The proportion of controls and MS patients after MS onset who reported using an individual HS was generally similar. The most commonly used HS in patients after MS was evening primrose oil (40.4%) followed by cranberry fruit extract (35.2%). There was no evidence for associations with progressive disease course or with choice of disease-modifying treatment. Dietary supplements are used more frequently by MS patients than controls. Use tends to increase after MS onset compared to before, especially for DS. The use of HS by MS patients is only modestly greater than by controls.
为了评估多发性硬化症(MS)患者的饮食(DS)和草药补充剂(HS)使用模式,比较 MS 患者与健康对照者之间的使用情况,并确定其与用于治疗 MS 的药物之间的潜在相互作用。本研究纳入了来自 MS 危险因素研究中的 279 名 MS 患者和 161 名对照者。所有患者均接受了神经系统检查。所有受试者均通过面对面访谈时的标准化问卷做出了回答。与对照组(60.1%)相比,MS 患者中(82.1%)定期使用一种或多种 DS 至少 3 个月的比例更大(p < 0.001)。与对照组(17.8%)相比,MS 患者(26.6%)中使用 HS 超过 1 个月的比例呈上升趋势(p = 0.038)。MS 发病后最常使用的 DS 是复合维生素(78.1%),其次是维生素 D(65.8%)。与发病前相比,大多数 DS 的使用在 MS 发病后明显增加。MS 发病后报告使用个别 HS 的对照组和 MS 患者的比例通常相似。MS 患者发病后最常使用的 HS 是月见草油(40.4%),其次是蔓越莓果提取物(35.2%)。没有证据表明与进行性疾病过程或疾病修正治疗的选择有关。膳食补充剂在 MS 患者中的使用频率高于对照组。与发病前相比,MS 发病后使用的趋势趋于增加,尤其是 DS。MS 患者使用 HS 的情况仅略高于对照组。